Evaluation of the effectiveness of additional risk minimisation measures (aRMMs) that aim to reduce the risks of phototoxicity, squamous cell carcinoma (SCC) of the skin and hepatic toxicity in patients receiving voriconazole in Saudi Arabia

30/10/2024
30/10/2025
EU PAS number:
EUPAS1000000266
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

A1501110_Non Interventional Study Protocol (Combined)_V1_16AUG2024_Redacted.pdf

English (558.23 KB - PDF) View document
Study results
Study report
Study report

A1501110_Non-Interventional Study Report_V1_20JUN2025_Redacted.pdf

English (627.65 KB - PDF) View document
Other information
Study, other information

A1501110_Non-Interventional Study Report_V2_03OCT2025_Redacted.pdf

English (376.25 KB - PDF) View document